Metabolomics in cell culture-A strategy to study crucial metabolic pathways in cancer development and the response to treatment

被引：67

作者：

Halama, Anna ^{[1
]}

机构：

[1] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar

来源：

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 2014年 / 564卷

关键词：

Metabolomics; Metabolic alterations; Cell culture; Cancer cell lines; Drug screening; BREAST-CANCER; PANCREATIC-CANCER; MASS-SPECTROMETRY; COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; PROFILING REVEALS; NMR METABOLOMICS; GENE-EXPRESSION; ACID PROFILES; OVARIAN;

D O I：

10.1016/j.abb.2014.09.002

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Metabolomics is a comprehensive tool for monitoring processes within biological systems. Thus, metabolomics may be widely applied to the determination of diagnostic biomarkers for certain diseases or treatment outcomes. There is significant potential for metabolomics to be implemented in cancer research because cancer may modify metabolic pathways in the whole organism. However, not all biological questions can be answered solely by the examination of small molecule composition in biofluids; in particular, the study of cellular processes or preclinical drug testing requires ex vivo models. The major objective of this review was to summarise the current achievement in the field of metabolomics in cancer cell culture focusing on the metabolic pathways regulated in different cancer cell lines and progress that has been made in the area of drug screening and development by the implementation of metabolomics in cell lines. (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：100 / 109

页数：10

共 156 条

[1] High content screening applied to large-scale cell biology [J].

Abraham, VC ;

Taylor, DL ;

Haskins, JR .

TRENDS IN BIOTECHNOLOGY, 2004, 22 (01) :15-22

[2] Characterization of Ovarian Cancer Cell Metabolism and Response to Chemotherapy by 31P Magnetic Resonance Spectroscopy [J].

Abramov, Yoram ;

Carmi, Shani ;

Anteby, Shaoul O. ;

Ringel, Israel .

ONCOLOGY RESEARCH, 2012, 20 (11) :529-536

[3] Genome-wide association studies with metabolomics [J].

Adamski, Jerzy .

GENOME MEDICINE, 2012, 4

[4]

Alcarraz-Vizan G., 2013, BIOCH BIPHYS ACTA GE

[5] Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer [J].

Arredouani, Mohamed S. ;

Lu, Bin ;

Bhasin, Manoj ;

Eljanne, Miriam ;

Yue, Wen ;

Mosquera, Juan-Miguel ;

Bubley, Glenn J. ;

Li, Vivian ;

Rubin, Mark A. ;

Libermann, Towia A. ;

Sanda, Martin G. .

CLINICAL CANCER RESEARCH, 2009, 15 (18) :5794-5802

[6]

Artati A, 2012, GENETICS MEETS METAB, P13

[7] Early Detection of Recurrent Breast Cancer Using Metabolite Profiling [J].

Asiago, Vincent M. ;

Alvarado, Leiddy Z. ;

Shanaiah, Narasimhamurthy ;

Gowda, G. A. Nagana ;

Owusu-Sarfo, Kwadwo ;

Ballas, Robert A. ;

Raftery, Daniel .

CANCER RESEARCH, 2010, 70 (21) :8309-8318

[8] A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma [J].

Averna, TA ;

Kline, EE ;

Smith, AY ;

Sillerud, LO .

JOURNAL OF UROLOGY, 2005, 173 (02) :433-438

[9]

Babina I.S., 2011, SEMIN CELL DEV BIOL

[10] Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer [J].

Baselga, Jose .

ONCOLOGIST, 2011, 16 :12-19

← 1 2 3 4 5 6 7 8 9 10 →